Scarica l'app Stockscreener
30.75
4.03%
-1.29
Dopo l'orario di chiusura:
30.68
-0.07
-0.23%
Precedente Chiudi:
$32.04
Aprire:
$32.42
Volume 24 ore:
1.92M
Relative Volume:
1.16
Capitalizzazione di mercato:
$1.86B
Reddito:
$362.27M
Utile/perdita netta:
$-85.19M
Rapporto P/E:
-21.21
EPS:
-1.45
Flusso di cassa netto:
$-68.71M
1 W Prestazione:
-3.57%
1M Prestazione:
+13.55%
6M Prestazione:
-20.03%
1 anno Prestazione:
-31.77%
Intervallo 1D:
$30.55
$33.00
Intervallo di 1 settimana:
$29.00
$33.86
Portata 52W:
$24.07
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Nome
Twist Bioscience Corp
Settore
Industria
Telefono
800-719-0671
Indirizzo
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Confronta TWST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
30.75 | 1.84B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-06-04 | Iniziato | Guggenheim | Buy |
| 2024-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-27 | Iniziato | Berenberg | Buy |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2023-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-29 | Iniziato | William Blair | Outperform |
| 2021-06-04 | Iniziato | Goldman | Neutral |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-02-05 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-11-26 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Twist Bioscience Corp Borsa (TWST) Ultime notizie
Is a relief rally coming for Twist Bioscience Corporation holdersPortfolio Gains Report & Daily Stock Trend Reports - newser.com
Is Twist Bioscience Corporation stock ready for breakoutTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Relative strength of Twist Bioscience Corporation in sector analysisJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Is Twist Bioscience Corporation forming a reversal pattern2025 Price Targets & Community Consensus Picks - newser.com
How sustainable is Twist Bioscience Corporation stock dividend payoutGap Up & Verified Stock Trade Ideas - newser.com
Twist Bioscience (NASDAQ:TWST) CFO Adam Laponis Sells 2,517 Shares - MarketBeat
Twist Bioscience (NASDAQ:TWST) CFO Adam Laponis Sells 3,000 Shares - MarketBeat
Twist Bioscience (NASDAQ:TWST) Shares Gap UpTime to Buy? - MarketBeat
Should Twist Bioscience's (TWST) Exclusive Access to New Sequencing Workflow Prompt Investor Attention? - Yahoo Finance
A Fresh Look at Twist Bioscience’s (TWST) Valuation After Its Recent 27% Share Price Surge - Yahoo Finance
Market reaction to Twist Bioscience Corporation’s recent news2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
Price action breakdown for Twist Bioscience CorporationQuarterly Performance Summary & Verified Stock Trade Ideas - newser.com
Twist Bioscience Corporation (NASDAQ:TWST) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Twist Bioscience's (TWST) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 31,348 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CFO Sells $189,116.25 in Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) SVP Sells $313,015.56 in Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Insider Sells $124,768.44 in Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 2,041 Shares - MarketBeat
Twist Bioscience (TWST) CEO Sells Over $1 Million in Shares - GuruFocus
Twist Bioscience (NASDAQ:TWST) Trading 6.9% HigherTime to Buy? - MarketBeat
Twist Bioscience Corp. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
Nasdaq Today Twist Bioscience Driving Biotech Innovation - Kalkine Media
Evercore ISI Lowers Twist Bioscience (NASDAQ:TWST) Price Target to $42.00 - MarketBeat
Twist Bioscience and Element launch new fast sequencing workflow - Investing.com
Twist Bioscience and Element launch new fast sequencing workflow By Investing.com - Investing.com Australia
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System - Business Wire
Will Twist Bioscience Corporation (0ME) stock keep high P E multiplesStock Surge & Stock Portfolio Risk Control - newser.com
Will Twist Bioscience Corporation (0ME) stock profit from fiscal stimulusJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Will Twist Bioscience Corporation stock recover after recent dropTrade Volume Report & Weekly High Potential Stock Alerts - newser.com
Twist Bioscience Corporation $TWST Holdings Lifted by HighMark Wealth Management LLC - MarketBeat
A Fresh Look at Twist Bioscience (TWST) Valuation Following Recent Trading Activity - simplywall.st
How Twist Bioscience Corporation (0ME) stock performs in volatility spikesJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Farther Finance Advisors LLC Sells 1,475 Shares of Twist Bioscience Corporation $TWST - Defense World
Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design - Business Wire
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Cuts Target Price to $40 - 富途牛牛
Twist Bioscience director Robert Chess sells shares totaling $156,216 - MSN
Green Paula, SVP at Twist Bioscience, sells $8k in shares By Investing.com - Investing.com Australia
Green Paula, SVP at Twist Bioscience, sells $8k in shares - Investing.com India
Dennis Cho sells Twist Bioscience (TWST) shares for $6,421 - Investing.com
Dennis Cho sells Twist Bioscience (TWST) shares for $6,421 By Investing.com - Investing.com Nigeria
Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience - Yahoo Finance
Is this a good reentry point in Twist Bioscience CorporationJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Chart based exit strategy for Twist Bioscience CorporationMarket Risk Report & Real-Time Buy Signal Alerts - newser.com
Can machine learning forecast Twist Bioscience Corporation recoveryEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Analyzing Twist Bioscience Corporation with risk reward ratio chartsWeekly Profit Summary & Verified Swing Trading Watchlist - newser.com
Market Overview: What analysts say about Twist Bioscience Corporation stockPortfolio Return Summary & AI Powered Market Entry Ideas - خودرو بانک
Twist Bioscience Corporation (NASDAQ:TWST) Receives $49.40 Average Price Target from Brokerages - MarketBeat
Visual trend scoring systems applied to Twist Bioscience CorporationJuly 2025 Setups & Safe Capital Allocation Plans - newser.com
Twist Bioscience Corporation stock chart pattern explainedM&A Rumor & Weekly High Conviction Ideas - newser.com
How to build a custom watchlist for Twist Bioscience CorporationJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Twist Bioscience Corp Azioni (TWST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Twist Bioscience Corp Azioni (TWST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Laponis Adam | Chief Financial Officer |
Oct 09 '25 |
Sale |
32.92 |
2,517 |
82,865 |
91,525 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):